450 related articles for article (PubMed ID: 33166575)
1. HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals.
Glebe D; Goldmann N; Lauber C; Seitz S
Antiviral Res; 2021 Feb; 186():104973. PubMed ID: 33166575
[TBL] [Abstract][Full Text] [Related]
2. A novel hepatitis B virus species discovered in capuchin monkeys sheds new light on the evolution of primate hepadnaviruses.
de Carvalho Dominguez Souza BF; König A; Rasche A; de Oliveira Carneiro I; Stephan N; Corman VM; Roppert PL; Goldmann N; Kepper R; Müller SF; Völker C; de Souza AJS; Gomes-Gouvêa MS; Moreira-Soto A; Stöcker A; Nassal M; Franke CR; Rebello Pinho JR; Soares MDCP; Geyer J; Lemey P; Drosten C; Netto EM; Glebe D; Drexler JF
J Hepatol; 2018 Jun; 68(6):1114-1122. PubMed ID: 29428874
[TBL] [Abstract][Full Text] [Related]
3. Molecular virology of hepatitis B virus and targets for antiviral intervention.
Glebe D; König A
Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480
[TBL] [Abstract][Full Text] [Related]
4. Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells.
König A; Yang J; Jo E; Park KHP; Kim H; Than TT; Song X; Qi X; Dai X; Park S; Shum D; Ryu WS; Kim JH; Yoon SK; Park JY; Ahn SH; Han KH; Gerlich WH; Windisch MP
J Hepatol; 2019 Aug; 71(2):289-300. PubMed ID: 31077792
[TBL] [Abstract][Full Text] [Related]
5. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.
Volz T; Allweiss L; Ben MBarek M; Warlich M; Lohse AW; Pollok JM; Alexandrov A; Urban S; Petersen J; Lütgehetmann M; Dandri M
J Hepatol; 2013 May; 58(5):861-7. PubMed ID: 23246506
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Hepatitis B Virus Receptor NTCP Reveals Differential Pathogenicities and Species Specificities of Hepadnaviruses in Primates, Rodents, and Bats.
Jacquet S; Pons JB; De Bernardo A; Ngoubangoye B; Cosset FL; Régis C; Etienne L; Pontier D
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541833
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus genetic diversity.
Echevarría JM; Avellón A
J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Hepatitis B Virus Infection Induces Cytopathic Effects in Primary Human Hepatocytes, and Can Be Partially Reversed by Antiviral Therapy.
Zai W; Hu K; Ye J; Ding J; Huang C; Li Y; Fang Z; Wu M; Wang C; Chen J; Yuan Z
Microbiol Spectr; 2022 Feb; 10(1):e0132821. PubMed ID: 35171034
[TBL] [Abstract][Full Text] [Related]
9. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
Hu Y; Cheng X; Cao F; Huang A; Tavis JE
Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
[TBL] [Abstract][Full Text] [Related]
10. Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes.
Drexler JF; Geipel A; König A; Corman VM; van Riel D; Leijten LM; Bremer CM; Rasche A; Cottontail VM; Maganga GD; Schlegel M; Müller MA; Adam A; Klose SM; Carneiro AJ; Stöcker A; Franke CR; Gloza-Rausch F; Geyer J; Annan A; Adu-Sarkodie Y; Oppong S; Binger T; Vallo P; Tschapka M; Ulrich RG; Gerlich WH; Leroy E; Kuiken T; Glebe D; Drosten C
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16151-6. PubMed ID: 24043818
[TBL] [Abstract][Full Text] [Related]
11. The evolution and clinical impact of hepatitis B virus genome diversity.
Revill PA; Tu T; Netter HJ; Yuen LKW; Locarnini SA; Littlejohn M
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):618-634. PubMed ID: 32467580
[TBL] [Abstract][Full Text] [Related]
12. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
13. The molecular virology of hepatitis B virus.
Glebe D; Bremer CM
Semin Liver Dis; 2013 May; 33(2):103-12. PubMed ID: 23749666
[TBL] [Abstract][Full Text] [Related]
14. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis B virus genetic diversity and mutant].
Yim HJ
Korean J Hepatol; 2008 Dec; 14(4):446-64. PubMed ID: 19119240
[TBL] [Abstract][Full Text] [Related]
17. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the Origin and Evolution of Hepatitis B Viruses by Means of a Family of Non-enveloped Fish Viruses.
Lauber C; Seitz S; Mattei S; Suh A; Beck J; Herstein J; Börold J; Salzburger W; Kaderali L; Briggs JAG; Bartenschlager R
Cell Host Microbe; 2017 Sep; 22(3):387-399.e6. PubMed ID: 28867387
[TBL] [Abstract][Full Text] [Related]
19. Drug targets in hepatitis B virus infection.
Stein LL; Loomba R
Infect Disord Drug Targets; 2009 Apr; 9(2):105-16. PubMed ID: 19275699
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
